e-ESO Podcasts

143 Epizód

1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

   Közzétéve: 2023. 02. 02.
2. Basics of prostate cancer pathology

   Közzétéve: 2023. 01. 26.
3. Oligometastaic breast cancer

   Közzétéve: 2023. 01. 19.
4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

   Közzétéve: 2023. 01. 12.
5. Summary/Review - Reporting Guidelines - CHEERS

   Közzétéve: 2022. 12. 06.
6. Role of immunotherapy in head and neck cancer

   Közzétéve: 2022. 12. 01.
7. AYAs with cancer: the right to be forgotten

   Közzétéve: 2022. 11. 24.
8. Summary/Review - Reporting Guidelines - SQUIRE

   Közzétéve: 2022. 11. 17.
9. Male breast cancer

   Közzétéve: 2022. 11. 10.
10. Summary/Review - Reporting Guidelines - SRQR

    Közzétéve: 2022. 11. 03.
11. Summary/Review - Reporting Guidelines - AGREE

    Közzétéve: 2022. 10. 27.
12. Breast Cancer: Frequently Asked Questions and Answers

    Közzétéve: 2022. 10. 20.
13. The role of Medical Physicist in Oncology

    Közzétéve: 2022. 10. 13.
14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Közzétéve: 2022. 10. 06.
15. Parp inhibitors in ovarian cancer

    Közzétéve: 2022. 09. 29.
16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Közzétéve: 2022. 09. 22.
17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Közzétéve: 2022. 09. 15.
18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Közzétéve: 2022. 09. 08.
19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Közzétéve: 2022. 09. 01.
20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Közzétéve: 2022. 07. 27.